We built the system that tells pharma what is really happening with patients at home — and what to do about it.
Built on patient trust and consent. Designed around patient voice.
Show me what you haveBy the time a survey lands on your desk, the experience it describes is already history.
By the time claims data surfaces a trend, the patient has already decided.
By the time your ad board meets, you're drawing conclusions about thousands from a room of eight.
What's missing isn't more data. It's the why behind the what.
That context lives at home. It never makes it into a survey response. The problem isn't the tools. It's that they were never designed to be there.
Not what they said in a focus group six months ago. Not what claims data will confirm next quarter. What is happening today, in the home, in real time — across your patients and your competitors' patients.
When KEEP identifies a patient showing readiness, a competitive threat forming, or a retention risk building — that intelligence routes to your brand team or agency with a recommended next move. Signal to action. No new workflow.
Most patient insight tools ask patients to represent themselves. KEEP observes them continuously.
A conversational health coach. Patients engage because it supports them, not because it surveys them. Kai observes language shifts, emotional tone, and what patients stop and start talking about — over months, not moments.
Passive, in-home. Sits where the medication already lives. Captures what patients actually do alongside what they say — grounding the intelligence Kai surfaces in real-world behavior.
Synthesizes what patients say and what they do. Surfaces the signal that matters. Routes to the right team at the right moment. Five defined signals routed to brand teams and agency partners.
Every month of continuous presence adds to the baseline. The intelligence compounds. Month one is good. Month twelve is irreplaceable. This is not a research project. It is infrastructure.
Select your stage to see where continuous patient intelligence changes what your team can know and when.
You're designing for patients you haven't met. Every decision you make now will be harder to reverse after launch.
Your brand is live. The question is whether it lands the way you designed it to — and whether you can see clearly enough to respond when it doesn't.
Your brand has traction. The signals that matter are quiet. Patient perception shifts before it shows up in share data.
Granular. Fast. Built on direct patient signal — not generalized panel data.
Granular patient intelligence. Faster than any other source. At a fraction of what you currently pay for generalizations.
Show me what you haveTell us where you play. We'll show you what we're already seeing from patients in that space.